Updates on CAR-T in Multiple Myeloma
Updates on CAR-T in Multiple Myeloma
Maximilian Merz
Patient Selection for Ciltacabtagene Autoleucel Therapy in R/R MM
- 113 views
- December 8, 2022
- 1
UChicago Medicine
Myeloma 2022: Challenges and Path Forward
FEATURING
Andrzej Jakubowiak
- 551 views
- August 19, 2022
- 3
GRACE
CAR T-Cell Therapy Side Effects for Blood Cancers
FEATURING
Aaron Goodman
- 2,254 views
- September 6, 2022
- 14
Rahul Banerjee
CAR-T Therapy in Myeloma: What's Here and What's Coming Soon
- 606 views
- October 18, 2022
- 4
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Pro CAR-T
FEATURING
Thomas Martin
- 242 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CAR T-Cell in MM - When To Use Now, Where Are We Going?
FEATURING
Noopur S. Raje
- 97 views
- October 14, 2022
- 1
UChicago Medicine
Identifying and Managing Major Toxicities of CAR-T Therapy in Multiple Myeloma
FEATURING
Satyajit Kosuri
- 73 views
- October 20, 2022
Enrique Ocio
Triple Refractory MM Patients: Learnings From the MAMMOTH and the LocoMMotion Trials
- 118 views
- October 5, 2022
- 1
ASH 2022 Conference Coverage
ASH 2022 Outcomes of Penta-Refractory MM Patients Based on Access to BCMA-Directed Therapy
FEATURING
Shebli Atrash
- 129 views
- December 19, 2022
- 2
ASH 2022 Conference Coverage
ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T Therapy in MM
FEATURING
Samir Parekh
- 67 views
- December 16, 2022
- 1
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Current Therapy
FEATURING
Kenneth Anderson
- 1,307 views
- January 18, 2023
- 7